HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

L16H50

a non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Chlorinated Hydrocarbons: 240
      - L16H50: 1

Experts

1.	Bai, Encheng: 1 article (01/2017)
2.	Cai, Yuepiao: 1 article (01/2017)
3.	Chen, Qiuxiang: 1 article (01/2017)
4.	Du, Xiaojing: 1 article (01/2017)
5.	Fu, Weitao: 1 article (01/2017)
6.	Jin, Rong: 1 article (01/2017)
7.	Kang, Yanting: 1 article (01/2017)
8.	Li, Wulan: 1 article (01/2017)
9.	Liang, Guang: 1 article (01/2017)
10.	Qiu, Peihong: 1 article (01/2017)

Related Diseases

1.	Stomach Neoplasms (Stomach Cancer) 01/01/2017 - "These results show that L16H50 is a potent non-ATP-competitive FGFR1 inhibitor and may provide strong rationale for its evaluation in gastric cancer patients."

Related Drugs and Biologics

1.	Adenosine Triphosphate (ATP)